Related Experiment Video
Updated: May 2, 2026

07:42
Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics
Published on: February 19, 2017
8.2K
Advanced Computational Techniques for Plasmonic Metasurfaces in the Detection of Neglected Infectious Diseases
Felipe M F Teixeira1,2, Ary V R Portes1,2, Talles E M Marques1,2
1Departamento de Engenharia Eletrônica, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Analytical Chemistry
|March 27, 2025
Summary
This tutorial explores plasmonic metasurfaces for sensitive, cost-effective diagnostics of neglected infectious diseases. It covers development from biofunctionalization to point-of-care use, aiming to overcome traditional assay limitations.
Area of Science:
- Biotechnology
- Nanotechnology
- Medical Diagnostics
Background:
- Traditional diagnostic methods for neglected infectious diseases often suffer from slow results and high costs.
- There is a need for advanced diagnostic tools that are both sensitive and cost-effective.
- Plasmonic metasurfaces offer a promising platform for overcoming these limitations.
Purpose of the Study:
- To provide a comprehensive tutorial on integrating plasmonic metasurfaces for sensitive diagnostic assays.
- To highlight the application of plasmonic metasurfaces in addressing neglected infectious diseases.
- To explore the complete development cycle of AI-driven plasmonic metasurfaces for diagnostics.
Main Methods:
- Biofunctionalization strategies for targeted detection.
- Advanced fabrication techniques for creating plasmonic metasurfaces.
- Integration of artificial intelligence (AI) for optimization.
Main Results:
- Plasmonic metasurfaces enable highly sensitive detection of disease biomarkers.
- This approach offers a transformative solution to limitations of traditional diagnostic assays.
- The tutorial outlines pathways for developing cost-effective and rapid diagnostic tools.
Conclusions:
- Plasmonic metasurfaces represent a cutting-edge tool for developing advanced diagnostic assays.
- The technology has the potential to significantly improve diagnostics for neglected infectious diseases.
- Addressing scalability, regulatory, and point-of-care challenges is crucial for widespread implementation.

